Phase II study of caffeine combined chemotherapy in patients with high- grade bone and soft tissue tumor
Phase 2
- Conditions
- High-grade bone and soft tissue tumor
- Registration Number
- JPRN-UMIN000001094
- Lead Sponsor
- Group for "Caffeine combined chemotherapy in patients with high-grade bone and soft tissue tumor"
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.sever drug allergy 2.uncontrolled diabetes mellitus 3.uncontrolled hypertension 4.women during pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The response rate of preoperative caffeine combined chemotherapy
- Secondary Outcome Measures
Name Time Method 2-year progression free survival, event-free survival, overall survival, incidence of adverse event